Natural products as a source of Alzheimer's drug leads

被引:348
作者
Williams, Philip [1 ,2 ]
Sorribas, Analia [1 ,2 ]
Howes, Melanie-Jayne R. [3 ]
机构
[1] Univ Hawaii Manoa, Dept Chem, Honolulu, HI 96822 USA
[2] Canc Res Ctr Hawaii, Honolulu, HI 96813 USA
[3] Royal Bot Gardens, Jodrell Lab, Richmond TW9 3AB, Surrey, England
关键词
PROTEIN-KINASE-C; BETA-AMYLOID FIBRILS; ACETYLCHOLINESTERASE-INHIBITORY-ACTIVITY; SECRETASE BACE1 INHIBITORS; LAVANDULAEFOLIA ESSENTIAL OIL; DISEASE-MODIFYING THERAPIES; GLYCOGEN-SYNTHASE KINASE-3; INDUCED MEMORY IMPAIRMENT; ALPHA-CONVERTING-ENZYME; PEROXIDE-INDUCED INJURY;
D O I
10.1039/c0np00027b
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
070307 [化学生物学]; 071010 [生物化学与分子生物学];
摘要
This review focuses on recent developments in the use of natural products as therapeutics for Alzheimer's disease. The compounds span a diverse array of structural classes and are organized according to their mechanism of action, with the focus primarily on the major hypotheses. Overall, the review discusses more than 180 compounds and summarizes 400 references.
引用
收藏
页码:48 / 77
页数:30
相关论文
共 400 条
[1]
Aggarwal BB, 2003, ANTICANCER RES, V23, P363
[2]
Effect of curcumin on brain insulin receptors and memory functions in STZ (ICV) induced dementia model of rat [J].
Agrawal, Rahul ;
Mishra, Bhanvi ;
Tyagi, Ethika ;
Nath, Chandishwar ;
Shukla, Rakesh .
PHARMACOLOGICAL RESEARCH, 2010, 61 (03) :247-252
[3]
Structural requirements for the flavonoid fisetin in inhibiting fibril formation of amyloid β protein [J].
Akaishi, Tatsuhiro ;
Morimoto, Takeo ;
Shibao, Mami ;
Watanabe, Sayaka ;
Sakai-Kato, Kumiko ;
Utsunomiya-Tate, Naoko ;
Abe, Kazuho .
NEUROSCIENCE LETTERS, 2008, 444 (03) :280-285
[4]
PALINURIN, A NEW LINEAR SESTERTERPENE FROM A MARINE SPONGE [J].
ALFANO, G ;
CIMINO, G ;
DESTEFANO, S .
EXPERIENTIA, 1979, 35 (09) :1136-1137
[5]
Antioxidant Therapy in Alzheimer's Disease: Theory and Practice [J].
Aliev, Gjumrakch ;
Obrenovich, Mark E. ;
Reddy, V. Prakash ;
Shenk, Justin C. ;
Moreira, Paula I. ;
Nunomura, Akihiko ;
Zhu, Xiongwei ;
Smith, Mark A. ;
Perry, George .
MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2008, 8 (13) :1395-1406
[6]
Marine compounds for the therapeutic treatment of neurological disorders [J].
Alonso, D ;
Castro, A ;
Martinez, A .
EXPERT OPINION ON THERAPEUTIC PATENTS, 2005, 15 (10) :1377-1386
[7]
*ALZF, 2007, FDA DEEMS US ALZH TR
[8]
Alzheimer A., 1907, Zentrabl, Nervenheilk., V30, P177
[9]
Alzheimer's Disease International, 2009, ALZH DIS INT WORLD A
[10]
Up-regulation of the Kv3.4 potassium channel subunit in early stages of Alzheimer's disease [J].
Angulo, E ;
Noé, V ;
Casadó, V ;
Mallol, J ;
Gomez-Isla, T ;
Lluis, C ;
Ferrer, I ;
Ciudad, CJ ;
Franco, R .
JOURNAL OF NEUROCHEMISTRY, 2004, 91 (03) :547-557